The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
The impact of sodium-glucose cotransporter-2 inhibitors on the outcome of patients with colorectal adenocarcinoma.
 
Cho Han Chiang
No Relationships to Disclose
 
Cho Hung Chiang
No Relationships to Disclose
 
YUANPING HSIA
No Relationships to Disclose
 
Xin Ya See
No Relationships to Disclose
 
Shih-Syuan Wang
No Relationships to Disclose
 
Yuan-Jen Chen
No Relationships to Disclose
 
Chun-Yu Peng
No Relationships to Disclose
 
Chuan-Sheng Horng
No Relationships to Disclose
 
Kit Yee Wong
No Relationships to Disclose
 
Aunchalee Jaroenlapnopparat
No Relationships to Disclose
 
Weitao Liu
No Relationships to Disclose
 
Cho Hsien Chiang
No Relationships to Disclose
 
Her-Shyong Shiah
No Relationships to Disclose
 
Tomas G. Neilan
Consulting or Advisory Role - Abbvie; Amgen; Bristol-Myers Squibb; C4 Therapeutics; CRC Oncology; Intrinsic Imaging; Parexel; Roche/Genentech; Sanofi
Research Funding - AstraZeneca; Bristol Myers Squibb Foundation